Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
ESC has record attendance | How to address CCTA staffing issues | FDA clears large-bore PE thrombectomy catheter
Thursday, September 4, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

ESC Congress broke new record with over 33,000 attendees

The European Society of Cardiology had nearly twice as many attendees as ACC this year, as the European meeting secures its place as the largest cardiology meeting in the world.

READ MORE >
The European Society of Cardiology (ESC) annual congress has become the largest cardiology in the world with more than 33,000 healthcare professionals at the 2025 meeting. Photo by ESC
Share on Twitter Share on Facebook Share on Linkedin

ESC Congress broke new record with over 33,000 attendees

Share on Twitter Share on Facebook Share on Linkedin
The European Society of Cardiology (ESC) annual congress has become the largest cardiology in the world with more than 33,000 healthcare professionals at the 2025 meeting. Photo by ESC
The European Society of Cardiology had nearly twice as many attendees as ACC this year, as the European meeting secures its place as the largest cardiology meeting in the world.
READ MORE >

How to address CCTA staffing shortages

Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years. 

READ MORE >
Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years.
Share on Twitter Share on Facebook Share on Linkedin

How to address CCTA staffing shortages

Share on Twitter Share on Facebook Share on Linkedin
Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years.
Jaime Warren, EdD, FACC, vice president of care transformation at MedAxiom, an ACC company, explains what is needed to address staffing shortages created by a 94% increase in cardiac CT volumes over the past 5 years. 
READ MORE >

FDA clears first large-bore, vacuum-assisted pulmonary embolism thrombectomy system

The Symphony Thrombectomy System eliminates tradeoffs between two priorities—leveraging large-bore power and ease of use vs. efficiently reducing clot burden and delivering improved speed. 

 

READ MORE >
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the first large-bore continuous vacuum-assisted system to treat pulmonary embolism (PE). The Symphony Thrombectomy System from Imperative Care Inc. enables physicians to remove more clot from the lungs in less time.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears first large-bore, vacuum-assisted pulmonary embolism thrombectomy system

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the first large-bore continuous vacuum-assisted system to treat pulmonary embolism (PE). The Symphony Thrombectomy System from Imperative Care Inc. enables physicians to remove more clot from the lungs in less time.
The Symphony Thrombectomy System eliminates tradeoffs between two priorities—leveraging large-bore power and ease of use vs. efficiently reducing clot burden and delivering improved speed.  
READ MORE >

Seeing is believing: New cath lab technology takes coronary stent visualization to the next level

Sponsored by GE HealthCare

The technologies and tools of the cardiac catheterization lab have evolved in recent years, allowing interventionalists to perform procedures with more precision than ever. Angiographic imaging, meanwhile, has remained relatively consistent—but that is all starting to change.

READ MORE >
ge_healthcare_3dstent_.png
Share on Twitter Share on Facebook Share on Linkedin

Seeing is believing: New cath lab technology takes coronary stent visualization to the next level

Sponsored by GE HealthCare

Share on Twitter Share on Facebook Share on Linkedin
ge_healthcare_3dstent_.png
The technologies and tools of the cardiac catheterization lab have evolved in recent years, allowing interventionalists to perform procedures with more precision than ever. Angiographic imaging, meanwhile, has remained relatively consistent—but that is all starting to change.
READ MORE >

Featured Articles

Medtronic’s RDN system approved in Japan

Hypertension is a significant issue in Japan, impacting an estimated 43 million adults. Medtronic's Symplicity Spyral RDN system is now approved for the treatment of those patients. 

READ MORE >
Medtronic Symplicity Spyral renal denervation
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s RDN system approved in Japan

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Symplicity Spyral renal denervation
Hypertension is a significant issue in Japan, impacting an estimated 43 million adults. Medtronic's Symplicity Spyral RDN system is now approved for the treatment of those patients. 
READ MORE >

Drug-coated balloons make little impact on PAD outcomes

Researchers tracked data from more than 3,000 patients, calling for more clinical trials of antiproliferative agents other than paclitaxel.

READ MORE >
leg veins chronic venous disease PAD peripheral artery disease
Share on Twitter Share on Facebook Share on Linkedin

Drug-coated balloons make little impact on PAD outcomes

Share on Twitter Share on Facebook Share on Linkedin
leg veins chronic venous disease PAD peripheral artery disease
Researchers tracked data from more than 3,000 patients, calling for more clinical trials of antiproliferative agents other than paclitaxel.
READ MORE >

Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm

The Varipulse PFA platform, which has already received FDA and CE mark approval, was linked to an adverse event rate of just 0.6%. 

READ MORE >
Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson’s PFA platform is both safe and effective, real-world data confirm

Share on Twitter Share on Facebook Share on Linkedin
Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.
The Varipulse PFA platform, which has already received FDA and CE mark approval, was linked to an adverse event rate of just 0.6%. 
READ MORE >

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes

GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Real-world data link semaglutide, tirzepatide to improved heart failure outcomes

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
GLP-1 drugs have been taking the United States by storm in recent years. According to a new study of more than 90,000 patients, some of these medications can also make a big impact on reducing adverse heart failure outcomes.
READ MORE >

Beta blockers ‘have no effect’ on heart attack patients

One researcher described the study's findings as "one of the most significant advances in heart attack treatment in decades.”

READ MORE >
Patient
Share on Twitter Share on Facebook Share on Linkedin

Beta blockers ‘have no effect’ on heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
Patient
One researcher described the study's findings as "one of the most significant advances in heart attack treatment in decades.”
READ MORE >

In Other News

Practices tied to private equity, hospitals charge significantly more than independent radiology groups

Negotiated professional prices for hospital-based radiology services are about 43% higher than independents vs. 16% more for PE-backed rad groups.

READ MORE >
scale money prices shopping transparency reimbursement dollar coins
Share on Twitter Share on Facebook Share on Linkedin

Practices tied to private equity, hospitals charge significantly more than independent radiology groups

Share on Twitter Share on Facebook Share on Linkedin
scale money prices shopping transparency reimbursement dollar coins
Negotiated professional prices for hospital-based radiology services are about 43% higher than independents vs. 16% more for PE-backed rad groups.
READ MORE >

Nine former CDC leaders warn of ‘raging fire’ ignited by RFK

In an open letter published in the New York Times, former CDC directors call on Congress to mitigate threats to public health caused by mass layoffs and cuts to critical programs. 

READ MORE >
Robert F. Kennedy Jr. secretary of health and human services (HHS). White House press photo
Share on Twitter Share on Facebook Share on Linkedin

Nine former CDC leaders warn of ‘raging fire’ ignited by RFK

Share on Twitter Share on Facebook Share on Linkedin
Robert F. Kennedy Jr. secretary of health and human services (HHS). White House press photo
In an open letter published in the New York Times, former CDC directors call on Congress to mitigate threats to public health caused by mass layoffs and cuts to critical programs. 
READ MORE >

GE HealthCare issues recall of C-arms due to missing shielding components

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare issues recall of C-arms due to missing shielding components

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 
READ MORE >

UnitedHealthcare sues Radiology Partners again, claiming mega practice ‘weaponized’ surprise billing protections

Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court. 

READ MORE >
UnitedHealthcare
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealthcare sues Radiology Partners again, claiming mega practice ‘weaponized’ surprise billing protections

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealthcare
Rad Partners "firmly" denied the allegations, which mirror a similar complaint from Aetna, contending it plans to "vigorously defend against these claims" in court. 
READ MORE >

Federal update would help imaging centers, rad practices qualify for small business loans

The Small Business Administration will raise receipts-based standards for 263 industries including imaging, allowing more to apply for financing.

READ MORE >
Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 
Share on Twitter Share on Facebook Share on Linkedin

Federal update would help imaging centers, rad practices qualify for small business loans

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 
The Small Business Administration will raise receipts-based standards for 263 industries including imaging, allowing more to apply for financing.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiology practice pays $3.5M in data breach settlement | Key ACC trials | More screening, treatment needed for CKD
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart
Hospital sues cardiology practice | Cardiologist fired for speaking out, lawsuit claims | FDA approves another GLP-1 pill
Week in Review: ‘Practice-changing’ cardiology research | Another Impella recall | FDA clears AI for pulmonary hypertension
Innovations at ACC 2026 | Lower drug costs increase medication compliance | TAVR temporary pacing lead cleared by FDA
March's Top Stories: 40 Under 40 | Court affirms death sentence for Texas nurse | Recreational Adderall use | TAVR innovation
Key takeaways from ACC.26 | FDA confirms recall for heart pumps | AI alerts deliver value | Practice adds in-house smart lab

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …14
    • Page 15
    • Page 16
    • Page 17
    • Current page 18
    • Page 19
    • Page 20
    • Page 21
    • Page 22 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup